|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Postmenopausal Osteoporosis | |||||
| Osteoporosis | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Osteoporosis, Postmenopausal | |||||
| 3 | More general conditions related to this trial | ||||
| Bone Diseases | |||||
| Bone Diseases, Metabolic | |||||
| Musculoskeletal Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| synthetic hPTH 1-34 | |||||
| 5 | Sponsors listed in this trial | ||||
| National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | |||||